Anxiolytic-like effect of neuropeptide Y (NPY) and NPY13-36 microinjected into vicinity of locus coeruleus in rats

Brain Research

Volumn 788, Issue 1-2, 1998, Pages 345-348

  Kask, Ants ^a   Rägo, Lembit ^a   Harro, Jaanus ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

Anxiety; Elevated plus maze; Exploration; Locus coeruleus; Neuropoptide Y

Indexed keywords

ANXIOLYTIC AGENT; NEUROPEPTIDE Y; NEUROPEPTIDE Y [13-36]; NEUROPEPTIDE Y [31 LEUCINE 34 PROLINE];

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; INTRACEREBRAL DRUG ADMINISTRATION; LOCUS CERULEUS; MALE; MAZE TEST; MICROINJECTION; NONHUMAN; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; LOCUS COERULEUS; MALE; MAZE LEARNING; MICROINJECTIONS; NEUROPEPTIDE Y; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR;

EID: 0345055310     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00076-6     Document Type: Article

References (27)

1. Abercrombie E.D., Jacobs B.L. Single-unit response of noradrenergic neurons in the locus coeruleus of freely moving cats: I. Acutely presented stressful and nonstressful stimuli. J. Neurosci. 7:1987;2837-2843.
2. Adamec R.E., McKay D. The effects of CRF and α-helical CRF on anxiety in normal and hypophysectomized rats. J. Psychopharmacol. 7:1993;346-354.
3. Broqua P., Wettstein J.G., Rocher M.N., Gauthier-Martin B., Junien J.L. Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures. Behav. Pharmacol. 6:1995;215-222.
4. Chen G., van den Pol A.N. Multiple NPY receptors coexist in pre- and postsynaptic sites: inhibition of GABA release in isolated self-innervated SCN neurons. J. Neurosci. 16:1996;7711-7724.
5. Chronwall B.M., DiMaggio D.A., Massari V.J., Pickel V.M., Ruggiero D.A., O'Donohue T.L. The anatomy of neuropeptide-Y-containing neurons in rat brain. Neuroscience. 15:1985;1159-1181.
6. 3H]BIBP3226. Neuroreport. 7:1996;901-904.
7. Everitt B.J., Hökfelt T., Terenius L., Tatemoto K., Mutt V., Goldstein M. Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat. Neuroscience. 11:1984;443-462.
8. Finta E.P., Regenold J.T., Illes P. Depression by neuropeptide Y of noradrenergic inhibitory postsynaptic potentials of locus coeruleus neurones. Naunyn-Schmiedeberg's Arch. Pharmacol. 346:1992;472-474.
9. S.L. Foote, G.S. Aston-Jones, Pharmacology and physiology of central noradrenergic systems, in: F.E. Bloom, D.J. Kupfer (Eds.), Psychopharmacology: the Fourth Generation of Progress, Raven Press, New York, 1995, pp. 335-345.
10. Gentsch C., Lichtsteiner M., Feer H. Open field and elevated plus-maze: a behavioural comparison between spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats and the effects of chlordiazepoxide. Behav. Brain Res. 25:1987;101-107.
11. Gerald C., Walker M.W., Criscione L., Gustafson E.L., Batzl-Hartmann C., Smith K.E., Vaysse P., Durkin M.M., Laz T.M., Linemeyer D.L., Schaffhauser A.O., Whitebread S., Hofbauer K.G., Taber R.I., Branchek T.A., Weinshank R.L. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature. 382:1996;168-171.
12. Handley S.L., Mithani S. Effects of α-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour. Naunyn-Schmiedeberg's Arch. Pharmacol. 327:1984;1-5.
13. J. Harro, Measurement of exploratory behavior in rodents, in: P.M. Conn (Ed.), Paradigms for the Study of Behavior. Methods in Neurosciences, Vol. 14, Academic Press, San Diego, 1993, pp. 359-377.
14. 1 receptors in amygdala and dissociation from food intake effects. Neuropsychopharmacology. 8:1993;357-363.
15. Heilig M., Söderpalm B., Engel J.A., Widerlöv E. Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacology. 98:1989;524-529.
16. Heilig M., Wahlestedt C., Widerlöv E. Neuropeptide Y (NPY)-induced suppression of activity in the rat: evidence for NPY receptor heterogeneity and for interaction with α-adrenoceptors. Eur. J. Pharmacol. 157:1988;205-213.
17. Heilig M., Murison R. Intracerebroventricular neuropeptide Y protects against stress-induced gastric erosion in the rat. Eur. J. Pharmacol. 137:1987;127-129.
18. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol. Biochem. Behav. 54:1996;21-30.
19. Holets V.R., Hökfelt T., Rökaeus A., Terenius L., Goldstein M. Locus coeruleus neurons in the rat containing neuropeptide Y, tyrosine hydroxylase or galanin and their efferent projections to the spinal cord, cerebral cortex and hypothalamus. Neuroscience. 24:1988;893-906.
20. 2-receptors the inhibitory effect of noradrenaline in rat locus coeruleus neurones. Naunyn-Schmiedeberg's Arch. Pharmacol. 348:1993;546-548.
21. 1 receptor antagonist BIBP3226: antagonism with diazepam. Eur. J. Pharmacol. 317:1996;R3-R4.
22. Lundkvist J., Chai Z., Teheranian R., Hasanvan H., Bartfai T., Jenck F., Widmer U., Moreau J.L. A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity. Eur. J. Pharmacol. 309:1996;195-200.
23. Michel M.C. Receptors for neuropeptide Y: multiple subtypes and multiple second messengers. Trends Pharmacol. Sci. 12:1991;389-394.
24. Pähkla R., Harro J., Rägo L. Behavioural effects of pinoline in the rat forced swimming, open field and elevated plus-maze tests. Pharmacol. Res. 34:1996;73-78.
25. Shibasaki T., Tsumori C., Hotta M., Imaki T., Demura H. Intracerebroventricular administration of neuropeptide Y inhibits release of noradrenaline in the hypothalamic paraventricular nucleus caused by manual restraint in the rat through an opioid system. Brain Res. 688:1995;189-192.
26. B.G. Stanley, Neuropeptide Y in multiple hypothalamic sites controls eating behaviour, endocrine, and autonomic systems for body energy balance, in: W.F. Colmers, C. Wahlestedt (Eds.), The Biology of Neuropeptide Y and Related Peptides, Humana Press, Totowa, 1993, pp. 457-509.
27. Wahlestedt C., Reis D.J. Neuropeptide Y-related peptides and their receptors - are the receptors potential therapeutic drug targets? Annu. Rev. Pharmacol. Toxicol. 32:1993;309-352.